In the BioHarmony Drug Report Database

"Preview" Icon

Anidulafungin

Eraxis, Ecalta (anidulafungin) is a small molecule pharmaceutical. Anidulafungin was first approved as Eraxis on 2006-02-17. It is used to treat abdominal abscess, candidemia, mycoses, and peritonitis in the USA. It has been approved in Europe to treat candidiasis. Eraxis’s patent is valid until 2021-04-12 (FDA).

 

Trade Name

 

Ecalta
 

Common Name

 

anidulafungin
 

ChEMBL ID

 

CHEMBL264241
 

Indication

 

abdominal abscess, candidemia, candidiasis, mycoses, peritonitis
 

Drug Class

 

Antifungal antibiotics (undefined group)

Image (chem structure or protein)

Anidulafungin structure rendering